Chemoinformaics analysis of trans-3-Hexenyl acetate
| Molecular Weight | 142.198 | nRot | 4 |
| Heavy Atom Molecular Weight | 128.086 | nRig | 0 |
| Exact Molecular Weight | 142.099 | nRing | 0 |
| Solubility: LogS | -7.084 | nHRing | 0 |
| Solubility: LogP | 8.415 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 24.2991 |
| nHD | 0 | BPOL | 16.6489 |
| QED | 0.315 |
| Synth | 1.095 |
| Natural Product Likeliness | 0.153 |
| NR-PPAR-gamma | 0.095 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.767 |
| MDCK | 0.00000864 |
| BBB | 0.112 |
| PPB | 0.983069 |
| VDSS | 3.848 |
| FU | 0.0158365 |
| CYP1A2-inh | 0.307 |
| CYP1A2-sub | 0.192 |
| CYP2c19-inh | 0.393 |
| CYP2c19-sub | 0.075 |
| CYP2c9-inh | 0.108 |
| CYP2c9-sub | 0.946 |
| CYP2d6-inh | 0.247 |
| CYP2d6-sub | 0.059 |
| CYP3a4-inh | 0.194 |
| CYP3a4-sub | 0.047 |
| CL | 4.564 |
| T12 | 0.069 |
| hERG | 0.233 |
| Ames | 0.007 |
| ROA | 0.035 |
| SkinSen | 0.951 |
| Carcinogencity | 0.036 |
| EI | 0.939 |
| Respiratory | 0.51 |
| NR-Aromatase | 0.036 |
| Antiviral | No |
| Prediction | 0.950314 |